Skip to content
★ Sign in to follow
SB

Sunil Bhonsle

CEO
Titan Pharmaceuticals Inc
Total declarations
23
Company
1
▲ Purchases (20 ops.)
€423k
▼ Sales (0 ops.)
—

Latest filing published 25 Sept 2018 for Titan Pharmaceuticals INC, €64k.

Filing timeline

BuySale
Sunil Bhonsle

Insider track record

Disclosed buys
20
Disclosed sells
0
Signal history

Closed purchases

Market purchases
20

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Sunil Bhonsle: trading record in brief

Sunil Bhonsle discloses dealings in Titan Pharmaceuticals Inc to SEC (Form 4). We count 23 filings; the first trade dates from 17 May 2007 and the latest from 21 September 2018.

Purchases make up the whole of the open-market record (20 purchases, €423k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 1 option exercise. Since January 2018: 1 purchase and no sales on the market.

Half of the purchases are above €17k and half below. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 25 September 2018, the filings show an open-market purchase worth €64k in Titan Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Sunil Bhonsle

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total

23 of 23 declarations